Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Hemorrhoids
Interventions
DRUG

Anusol

Daily at night and in the morning and after each bowel movement for two weeks

DRUG

Relief [Name]

Daily at night and in the morning and after each bowel movement for two weeks

DRUG

Placebo

Daily at night and in the morning and after each bowel movement for two weeks

Trial Locations (2)

Unknown

Erebouni Medical Center, Yerevan

Izmirlyan Medical Center, Yerevan

All Listed Sponsors
lead

Church & Dwight Company, Inc.

INDUSTRY

NCT05157711 - Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids | Biotech Hunter | Biotech Hunter